Immunogenicity 10483

summary
Sample ID
3812
Response
Negative
Tumor Type
Bile duct cancer
Gene Symbol
BHMT
Transcript ID
uc011cti.2
HLA INFO
C*07:02
TCR INFO

No TCR info found!

T cell Tumor cell C*07:02
sequence
Full length protein sequence (253 aa)
MPPVG
1
GKKAK
6
KGILE
11
RLNAG
16
EIVIG
21
DGGFV
26
FALEK
31
RGYVK
36
AGPWT
41
PEAAV
46
EHPEA
51
GASII
56
GVNCH
61
FDPTI
66
SLKTV
71
KLMKE
76
GLEAA
81
RLKAH
86
LMSQP
91
LAYHT
96
PDCNK
101
QGFID
106
LPEFP
111
FGLEP
116
RVATR
121
WDIQK
126
YAREA
131
YNLGV
136
RYIGG
141
CCGFE
146
PYHIR
151
AIAEE
156
LAPER
161
GFLPP
166
ASEKH
171
GSWGS
176
GLDMH
181
TKPWV
186
RARAR
191
KEYWE
196
NLRIA
201
SGRPY
206
NPSMS
211
KPDGW
216
GVTKG
221
TAELM
226
QQKEA
231
TTEQQ
236
LKELF
241
EKQKF
246
KSQ
251
Mutation Information
DNA mutation:
None
Peptide Range:
134 ~ 158
Mut AA position:
146 (13 in Wild Type peptide)
Alignment
Wild Type:
"EAYNLGVRYIGGCCGFEPYHIRAIA
||||||||||||.||||||||||||
Mutant:
EAYNLGVRYIGGGCGFEPYHIRAIA"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) BHMT

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

None

Assay

IFNg ELISPOT assay